Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Personalis Slides 14.6% as Tempus Buyout Terms Trigger Deal-Spread Reset

None

Personalis (PSNL) is down 14.6% today. Here is some analysis on what might have caused this price movement. ([investors.personalis.com](https://investors.personalis.com/news-releases/news-release-details/tempus-acquire-personalis-more-tightly-integrating-molecular))

Analysis: The most likely driver is the market’s reaction to Tempus AI’s agreement to acquire Personalis, with traders repricing PSNL to the economics and risk of the merger rather than treating the announced $16.25 figure as guaranteed cash. Because the consideration is primarily stock, capped by a maximum exchange ratio, and the deal is not expected to close until late 2026 or early 2027, weakness in Tempus shares and normal merger-arbitrage discounting appear to have pushed Personalis lower. ([investors.personalis.com](https://investors.personalis.com/news-releases/news-release-details/tempus-acquire-personalis-more-tightly-integrating-molecular))

Details:

  • Tempus announced on July 20, 2026 that it will acquire Personalis in a transaction valuing the target at $16.25 per share and about $1.5 billion enterprise value. ([investors.personalis.com](https://investors.personalis.com/news-releases/news-release-details/tempus-acquire-personalis-more-tightly-integrating-molecular))
  • The merger consideration is structured as a 100% stock deal, although Tempus can elect to pay up to 50% in cash, which means the value received by PSNL holders is still tied in part to Tempus share performance. ([investors.personalis.com](https://investors.personalis.com/news-releases/news-release-details/tempus-acquire-personalis-more-tightly-integrating-molecular))
  • The agreement uses a floating exchange ratio with a maximum of 0.3356 Tempus shares per Personalis share, so a drop in Tempus can reduce the effective value implied by the stock component. ([investors.personalis.com](https://investors.personalis.com/news-releases/news-release-details/tempus-acquire-personalis-more-tightly-integrating-molecular))
  • Tempus shares were also sharply lower today, while Personalis ended well below its intraday high, a pattern consistent with merger-spread trading and closing-risk discounting. Personalis also disclosed preliminary second-quarter revenue of $22.4 million and 10,384 clinical tests, but those positives were overshadowed by deal mechanics. ([investors.personalis.com](https://investors.personalis.com/news-releases/news-release-details/tempus-acquire-personalis-more-tightly-integrating-molecular))
  • Sources:

    Personalis Investor Relations, SEC, MarketBeat

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $PSNL Insider Trading Activity

    PSNL Insider Trades

    $PSNL insiders have traded $PSNL stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

    Here’s a breakdown of recent trading of $PSNL stock by insiders over the last 6 months:

    • CHRISTOPHER M HALL (Chief Executive Officer) has made 0 purchases and 4 sales selling 300,000 shares for an estimated $3,925,000.
    • AARON TACHIBANA (CFO AND COO) has made 0 purchases and 5 sales selling 136,233 shares for an estimated $1,688,740.
    • RICHARD CHEN (President and CMO) sold 100,000 shares for an estimated $1,515,000

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    EARLY ACCESS
    Receive PSNL Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $PSNL Hedge Fund Activity

    We have seen 67 institutional investors add shares of $PSNL stock to their portfolio, and 51 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $PSNL Government Contracts

    We have seen $13,500,000 of award payments to $PSNL over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

    $PSNL Analyst Ratings

    Wall Street analysts have issued reports on $PSNL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • BTIG issued a "Buy" rating on 02/11/2026

    To track analyst ratings and price targets for $PSNL, check out Quiver Quantitative's $PSNL forecast page.

    $PSNL Price Targets

    Multiple analysts have issued price targets for $PSNL recently. We have seen 4 analysts offer price targets for $PSNL in the last 6 months, with a median target of $12.5.

    Here are some recent targets:

    • Tejas Savant from Morgan Stanley set a target price of $13.0 on 07/09/2026
    • Mark Massaro from BTIG set a target price of $11.0 on 05/11/2026
    • Mike Matson from Needham set a target price of $12.0 on 02/27/2026
    • Subbu Nambi from Guggenheim set a target price of $13.0 on 01/26/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles